|
Originally published In Press as doi:10.1074/jbc.M508303200 on September 6, 2005
J. Biol. Chem., Vol. 280, Issue 45, 37877-37884, November 11, 2005
Molecular Basis for Zinc Potentiation at Strychnine-sensitive Glycine Receptors*
Paul S. Miller1,
Helena M. A. Da Silva, and
Trevor G. Smart2
From the
Department of Pharmacology, University College London, Gower Street, London WC1E 6BT, United Kingdom
The divalent cation Zn2+ is a potent potentiator at the strychnine-sensitive glycine receptor (GlyR). This occurs at nanomolar concentrations, which are the predicted endogenous levels of extracellular neuronal Zn2+. Using structural modeling and functional mutagenesis, we have identified the molecular basis for the elusive Zn2+ potentiation site on GlyRs and account for the differential sensitivity of GlyR 1 and GlyR 2 to Zn2+ potentiation. In addition, juxtaposed to this Zn2+ site, which is located externally on the N-terminal domain of the subunit, another residue was identified in the nearby Cys loop, a region that is critical for receptor gating in all Cys loop ligand-gated ion channels. This residue acted as a key control element in the allosteric transduction pathway for Zn2+ potentiation, enabling either potentiation or overt inhibition of receptor activation depending upon the moiety resident at this location. Overall, we propose that Zn2+ binds to a site on the extracellular outer face of the GlyR subunit and exerts its positive allosteric effect via an interaction with the Cys loop to increase the efficacy of glycine receptor gating.
Received for publication, July 28, 2005
* This work was supported by the Medical Research Council and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 A Wellcome Trust four year Ph.D. postgraduate student.
2 To whom correspondence should be addressed: Dept. of Pharmacology, University College London, Gower St., London, WC1E 6BT, United Kingdom. Tel.: 0207-679-2013; Fax: 0207-679-7298; E-mail: t.smart{at}ucl.ac.uk.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Rousseau, K. R. Aubrey, and S. Supplisson
The Glycine Transporter GlyT2 Controls the Dynamics of Synaptic Vesicle Refilling in Inhibitory Spinal Cord Neurons
J. Neurosci.,
September 24, 2008;
28(39):
9755 - 9768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Madry, H. Betz, J. R. P. Geiger, and B. Laube
Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist
PNAS,
August 26, 2008;
105(34):
12563 - 12568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jenkins, I. A. Lobo, D. Gong, J. R. Trudell, K. Solt, R. A. Harris, and E. I. Eger II
General Anesthetics Have Additive Actions on Three Ligand Gated Ion Channels
Anesth. Analg.,
August 1, 2008;
107(2):
486 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci.,
July 2, 2008;
28(27):
6884 - 6894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. R. Plested, P. J. Groot-Kormelink, D. Colquhoun, and L. G. Sivilotti
Single-channel study of the spasmodic mutation {alpha}1A52S in recombinant rat glycine receptors
J. Physiol.,
May 15, 2007;
581(1):
51 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|